Volastra's VLS-1488 Shows Promise in Ovarian Cancer Trial

Volastra Therapeutics has been working on an oral kinesin family member 18A (KIF18A) inhibitor, known as VLS-1488. What exactly does that mean, you might ask? Well, kinesin family members are proteins that play a crucial role in cell division. They're like the little workers inside our cells that help pull things apart and organize